TVTX: Travere Therapeutics, Inc. Common Stock Company Profile & Statistics

Travere Therapeutics, Inc. Common Stock Profile

Info & Links

CEO

Eric Dube

Headquarters

3611 VALLEY CENTRE DR, SUITE 300
SAN DIEGO, CA 92130, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

173

Employees

385

Travere Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

2.14B

Enterprise Value

2.45B

Enterprise Value/EBITDA(ttm)

-19.60

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

96.74%

Operating Margin(ttm)

Profit Margin(ttm)

-57.33%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-51.62%

Return on Assets(ttm)

Income Statement

Revenue(ttm)

333.87M

Revenue Per Share(ttm)

3.75

Gross Profit(ttm)

323.49M

EBITDA(ttm)³

-124.87M

Net Income Available to Common(ttm)

-169.06M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

66.91%

S&P 500 52-Week Change

18.18%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

89.14M

Dividend Yield

Float⁴

% Held by Insiders

% Held by Institutions

Balance Sheet

Total Cash(mrq)

319.54M

Total Cash Per Share(mrq)

3.58

Total Debt(mrq)

379.85M

Total Debt/Equity(mrq)

1159.97%

Current Ratio(mrq)

2.00%

Quick Ratio(mrq)

Book Value Per Share(mrq)

0.37

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.42

Free Cash Flow(ytd)

-37.45M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TVTX

Travere Therapeutics, Inc. Common Stock